Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

257 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Melphalan 200 mg/m(2) versus melphalan 100 mg/m(2) in newly diagnosed myeloma patients: a prospective, multicenter phase 3 study.
Palumbo A, Bringhen S, Bruno B, Falcone AP, Liberati AM, Grasso M, Ria R, Pisani F, Cangialosi C, Caravita T, Levi A, Meloni G, Nozza A, Pregno P, Gabbas A, Callea V, Rizzo M, Annino L, De Stefano V, Musto P, Baldi I, Cavallo F, Petrucci MT, Massaia M, Boccadoro M. Palumbo A, et al. Among authors: petrucci mt. Blood. 2010 Mar 11;115(10):1873-9. doi: 10.1182/blood-2009-09-241737. Epub 2009 Dec 1. Blood. 2010. PMID: 19965659 Free article. Clinical Trial.
[Therapy of multiple myeloma and its complications].
Avvisati G, Pulsoni A, Petrucci MT, Tribalto M. Avvisati G, et al. Among authors: petrucci mt. Recenti Prog Med. 1990 Oct;81(10):642-50. Recenti Prog Med. 1990. PMID: 2291008 Review. Italian.
[Therapy of multiple myeloma].
La Verde G, Pulsoni A, Petrucci MT, Mandelli F. La Verde G, et al. Among authors: petrucci mt. Recenti Prog Med. 1997 Apr;88(4):186-93. Recenti Prog Med. 1997. PMID: 9206817 Review. Italian.
High-dose hydroxyurea in the treatment of poor-risk myeloid leukemias.
Petti MC, Tafuri A, Latagliata R, Aloe Spiriti MA, Montefusco E, Mancini M, Meloni G, Petrucci MT, Spadea A, Redi R, Alimena G, Mandelli F. Petti MC, et al. Among authors: petrucci mt. Ann Hematol. 2003 Aug;82(8):476-480. doi: 10.1007/s00277-003-0693-2. Epub 2003 Jun 26. Ann Hematol. 2003. PMID: 12835916
Intermediate-dose cyclophosphamide and granulocyte colony-stimulating factor is a valid alternative to high-dose cyclophosphamide for mobilizing peripheral blood CD34+ cells in patients with multiple myeloma.
Petrucci MT, Avvisati G, La Verde G, De Fabritiis P, Ribersani M, Palumbo G, De Felice L, Rusignuolo A, Simone F, Meloni G, Mandelli F. Petrucci MT, et al. Acta Haematol. 2003;109(4):184-8. doi: 10.1159/000070967. Acta Haematol. 2003. PMID: 12853690
257 results